The Regis Healthcare Ltd (ASX: REG) share price is in focus today after the company announced the appointment of Andrew Kinkade as its new Managing Director and Chief Executive Officer. Kinkade joins Regis with an extensive leadership background in aged care, healthcare and finance.
What did Regis Healthcare report?
- Appointment of Andrew Kinkade as new Managing Director & CEO, commencing 20 July 2026
- Total fixed remuneration of $900,000 per annum, inclusive of superannuation
- Short Term Incentive of up to 50% of TFR and Long Term Incentive of up to 100% of TFR, subject to performance
- Sign-on equity award of $1.6 million in Performance Rights, subject to shareholder approval
What else do investors need to know?
Andrew Kinkade brings more than 20 years of experience across aged care, healthcare, private equity, and investment banking, most recently serving as Managing Director at Bupa Villages & Aged Care. He has been recognised for leading operational and cultural transformation, driving both growth and improved care standards.
Kinkade replaces Dr Linda Mellors, who will complete her notice period in June after leading the company for over six years. The board expressed its appreciation for Dr Mellors’ significant contributions and steady leadership throughout her tenure.
What’s next for Regis Healthcare?
Kinkade’s appointment signals a focus on operational transformation and strengthening Regis’s position in Australia’s aged care sector. The Board noted his track record of leading growth in regulated, people-focused businesses, which aligns with Regis Healthcare’s strategic objectives.
Shareholders will vote on key elements of Kinkade’s remuneration package, including his sign-on equity award, at the upcoming Annual General Meeting. The company expects a smooth transition and ongoing delivery on its growth plans.
Regis Healthcare share price snapshot
Over the past 12 months, Regis Healthcare shares have declined 2%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 8% over the same period.
The post Regis Healthcare names Andrew Kinkade as new CEO appeared first on The Motley Fool Australia.
Should you invest $1,000 in Regis Healthcare right now?
Before you buy Regis Healthcare shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Regis Healthcare wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Zimplats shares: Production dips and costs rise
- Woodside Q1 2026 earnings: Revenue grows, Scarborough and Trion progress
- Liontown shares: Expansion works begin at Kathleen Valley
- Codan FY26 earnings surge more than 60% on strong communications segment
- Capricorn Metals reports record cash flow and first dividend in March 2026 quarter
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.